Quantum Biopharma (QNTM) Competitors $23.70 +0.23 (+0.98%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$23.18 -0.52 (-2.22%) As of 08/1/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock QNTM vs. ZYBT, SCPH, INZY, VOR, ACB, ANNX, AARD, NBTX, IMMP, and SOPHShould you be buying Quantum Biopharma stock or one of its competitors? The main competitors of Quantum Biopharma include Zhengye Biotechnology (ZYBT), scPharmaceuticals (SCPH), Inozyme Pharma (INZY), Vor Biopharma (VOR), Aurora Cannabis (ACB), Annexon (ANNX), Aardvark Therapeutics (AARD), Nanobiotix (NBTX), Prima BioMed (IMMP), and SOPHiA GENETICS (SOPH). These companies are all part of the "pharmaceutical products" industry. Quantum Biopharma vs. Its Competitors Zhengye Biotechnology scPharmaceuticals Inozyme Pharma Vor Biopharma Aurora Cannabis Annexon Aardvark Therapeutics Nanobiotix Prima BioMed SOPHiA GENETICS Quantum Biopharma (NASDAQ:QNTM) and Zhengye Biotechnology (NASDAQ:ZYBT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends. Does the media refer more to QNTM or ZYBT? In the previous week, Quantum Biopharma and Quantum Biopharma both had 1 articles in the media. Zhengye Biotechnology's average media sentiment score of 0.59 beat Quantum Biopharma's score of 0.00 indicating that Zhengye Biotechnology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantum Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Zhengye Biotechnology 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, QNTM or ZYBT? Zhengye Biotechnology has higher revenue and earnings than Quantum Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuantum BiopharmaN/AN/A-$14.20M-$15.98-1.48Zhengye Biotechnology$186.36M1.34$1.55MN/AN/A Is QNTM or ZYBT more profitable? Zhengye Biotechnology's return on equity of 0.00% beat Quantum Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Quantum BiopharmaN/A -155.20% -94.90% Zhengye Biotechnology N/A N/A N/A Do insiders and institutionals hold more shares of QNTM or ZYBT? 1.2% of Quantum Biopharma shares are held by institutional investors. 8.5% of Quantum Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryZhengye Biotechnology beats Quantum Biopharma on 5 of the 7 factors compared between the two stocks. Get Quantum Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for QNTM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QNTM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QNTM vs. The Competition Export to ExcelMetricQuantum BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$68.24M$3.00B$5.49B$9.52BDividend YieldN/A2.43%4.73%4.09%P/E Ratio-1.4817.6228.7523.81Price / SalesN/A179.21372.2066.02Price / CashN/A41.9535.4557.96Price / Book5.228.508.275.55Net Income-$14.20M-$55.06M$3.25B$259.20M7 Day Performance-5.77%-3.99%-3.72%-4.64%1 Month Performance23.70%9.58%4.30%4.41%1 Year PerformanceN/A6.70%25.87%17.95% Quantum Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QNTMQuantum BiopharmaN/A$23.70+1.0%N/AN/A$68.24MN/A-1.48N/AGap DownZYBTZhengye BiotechnologyN/A$5.69flatN/AN/A$268.38M$25.53M0.00278News CoverageAnalyst UpgradeSCPHscPharmaceuticals3.8033 of 5 stars$5.13+3.8%$14.00+172.9%+7.9%$260.79M$41.98M-2.6930News CoverageINZYInozyme Pharma2.1223 of 5 stars$4.00flat$11.75+193.8%N/A$258.25MN/A-2.3750News CoverageUpcoming EarningsVORVor Biopharma3.2859 of 5 stars$2.05-7.2%$5.63+174.6%+123.4%$256.17MN/A-1.24140Gap DownACBAurora Cannabis0.3762 of 5 stars$4.70+3.8%N/A-26.0%$254.80M$246.72M42.731,130Upcoming EarningsANNXAnnexon2.2204 of 5 stars$2.47+6.5%$12.50+406.1%-59.8%$254.54MN/A-2.0960Gap DownAARDAardvark TherapeuticsN/A$12.00+3.3%$33.00+175.0%N/A$252.11MN/A0.0018NBTXNanobiotix0.8402 of 5 stars$5.11-3.6%$8.00+56.6%+21.1%$249.81M$39.18M0.00100IMMPPrima BioMed1.4453 of 5 stars$1.71+0.6%$7.00+309.4%-17.1%$248.27MN/A0.002,021News CoverageSOPHSOPHiA GENETICS1.633 of 5 stars$3.49-6.2%$7.00+100.6%-29.6%$248.08M$65.17M-3.49520Upcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies Zhengye Biotechnology Alternatives scPharmaceuticals Alternatives Inozyme Pharma Alternatives Vor Biopharma Alternatives Aurora Cannabis Alternatives Annexon Alternatives Aardvark Therapeutics Alternatives Nanobiotix Alternatives Prima BioMed Alternatives SOPHiA GENETICS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QNTM) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quantum Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quantum Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
